SIEGALL CLAY B (President and CEO) received a stock award from IMMUNOME INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/27/2026ACC: 0001167496-26-000005
DirectorOfficer· President and CEO
Since Oct 2023
+540K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
540K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+180K
Price / share
—
Trade value
—
% of position
26.1%
7/23/2026
690.70K→870.70K
Total
Net shares
+180K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/23/2026 | A · Award | +180K | — | — | 26.1% | 690.70K | 870.70K |
| Total | +180K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
360K shares
Shares
+360K
Strike price
22.01
Held after
360K
Exercisable
—
7/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock360K shares | 7/23/2026 | A · Award | +360K | 22.01 | — | 360K |